Search Results - "Alfadhli, Ahmad"

Refine Results
  1. 1

    Effectiveness of vedolizumab and ustekinumab as second biologic agent in achieving target outcomes in tumor necrosis factor antagonists experienced patients with inflammatory bowel disease (enroll-ex study) by Alrashed, Fatema, Abdullah, Israa, Alfadhli, Ahmad, Shehab, Mohammad

    Published in Frontiers in pharmacology (09-10-2023)
    “…Background: About a third of patients with inflammatory bowel disease (IBD) do not respond to anti-tumor necrosis factor (anti-TNF) therapy. In our study, we…”
    Get full text
    Journal Article
  2. 2

    Effectiveness of biologic therapies in achieving treatment targets in inflammatory bowel disease; real-world data from the Middle East (ENROLL study) by Shehab, Mohammad, Alfadhli, Ahmad, Abdullah, Israa, Alostad, Wrood, Marei, Alaa, Alrashed, Fatema

    Published in Frontiers in pharmacology (16-10-2024)
    “…Real-world data assessing the effectiveness of biologics in patients with inflammatory bowel disease (IBD) in the Middle East are not well-established. In our…”
    Get full text
    Journal Article
  3. 3

    A randomized clinical trial comparing triple therapy versus non-bismuth based quadruple therapy for the eradication of Helicobacter Pylori in Kuwait by Alfadhli, Ahmad, Alboraie, Mohamed, Afifi, Mostafa, Dangi, Abhijit

    Published in Journal of global infectious diseases (01-07-2022)
    “…Introduction: Helicobacter pylori-induced chronic infection is associated with peptic ulcer, chronic gastritis, gastric cancer, and increasing antibiotic…”
    Get full text
    Journal Article
  4. 4

    Adherence to Recommended Immunization Schedules in Patients with Inflammatory Bowel Disease on Biologics and Small Molecule Therapies by Shehab, Mohammad, Almatar, Ranim, Almohammad, Rawan, Alfadhli, Ahmad

    Published in Gastroenterology insights (01-09-2023)
    “…Introduction: Patients with inflammatory bowel disease (IBD) on biologic therapies are at increased risk of infections, emphasizing the importance of…”
    Get full text
    Journal Article
  5. 5

    COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study by Shehab, Mohammad, Alrashed, Fatema, Alfadhli, Ahmad

    Published in Vaccines (Basel) (22-07-2022)
    “…Background: Vaccination has been effective in preventing COVID-19 infections and related mortality. However, waning immunity after two-dose vaccination…”
    Get full text
    Journal Article
  6. 6

    Predictive Factors of Significant Findings on Capsule Endoscopy in Patients with Suspected Small Bowel Bleeding by Alali, Ali A, Alrashidi, Reem, Allahow, Farah, Dangi, Abhijit, Alfadhli, Ahmad

    Published in Diagnostics (Basel) (22-10-2024)
    “…Background: Small bowel capsule endoscopy (SBCE) is an established non-invasive diagnostic modality for a variety of small bowel pathologies and has a…”
    Get full text
    Journal Article
  7. 7

    Immunogenicity of Hepatitis B Vaccination in Patients with Ulcerative Colitis on Infliximab Is Attenuated Compared to Those on 5-Aminosalicylic Acid Therapies: A Prospective Observational Study by Shehab, Mohammad, Alrashed, Fatema, Alyaseen, Munerah, Safar, Zainab, Adekunle, Tunrayo, Alfadhli, Ahmad, Bessissow, Talat

    Published in Vaccines (Basel) (01-04-2024)
    “…Hepatitis B virus (HBV) infection has been associated with chronic hepatitis and cirrhosis. Patients with inflammatory bowel disease (IBD) may be at a higher…”
    Get full text
    Journal Article
  8. 8

    Effectiveness of inspectors' team in increasing compliance with personal protective equipment use and reducing COVID19 infection spread among healthcare workers by Shehab, Mohammad, Shuaibi, Sameera, Qadhi, Iman, Alfadhli, Ahmad

    Published in Infection prevention in practice (01-06-2021)
    “…Healthcare workers (HCW) were amongst the front-liners in the mission to tackle the COVID-19 pandemic and thus bore a huge risk of infection. Therefore,…”
    Get full text
    Journal Article
  9. 9

    COVID-19 Vaccine Hesitancy among Patients with Inflammatory Bowel Disease Receiving Biologic Therapies in Kuwait: A Cross-Sectional Study by Shehab, Mohammad, Zurba, Yasmin, Al Abdulsalam, Ali, Alfadhli, Ahmad, Elouali, Sara

    Published in Vaccines (Basel) (31-12-2021)
    “…COVID-19 vaccinations have been shown to be effective in reducing risk of severe infection, hospitalization, and death. They have also been shown to be safe…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Relationship Between Patient Sex and Serum Tumor Necrosis Factor Antagonist Drug and Anti-drug Antibody Concentrations in Inflammatory Bowel Disease; A Nationwide Cohort Study by Shehab, Mohammad, Alasfour, Hajer, Abdullah, Israa, Alhendi, Ghadeer, Alhadab, Anwar, Alfadhli, Ahmad, Ziyab, Ali H, Battat, Robert

    Published in Frontiers in medicine (23-12-2021)
    “…Anti-drug antibodies to infliximab (ATI) and adalimumab (ATA) are associated with loss of response to tumor necrosis factor antagonist (anti-TNF) therapy in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Quadruple therapy versus standard triple therapy for eradication of Helicobacter pylori in Kuwait by Alboraie, Mohamed, Saad, Motaz, Al-Ali, Jaber, Malik, Mohammad, Asem, Noha, Schmidt, Imre, Alfadhli, Ahmad A.

    Published in Arab journal of gastroenterology (01-09-2015)
    “…Chronic infection caused by Helicobacter pylori (H. pylori) is associated with chronic gastritis, peptic ulcer disease, and gastric cancer. Eradication of H…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Relationship between Ustekinumab trough concentrations and clinical, biochemical and endoscopic outcomes in Crohn's disease: A multi-center nationwide retrospective study (TARGET STUDY) by Shehab, Mohammad, Abdullah, Israa, Alfadhli, Ahmad, Alrashed, Fatema

    Published in Medicine (Baltimore) (05-07-2024)
    “…Ustekinumab has been shown to be effective in inducing and maintain clinical and endoscopic remission in Crohn disease (CD). We aim to assess whether…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Accelerating the elimination of hepatitis C in Kuwait: An expert opinion by Hasan, Fuad, Alfadhli, Ahmad, Al-Gharabally, Abeer, Alkhaldi, Mahmoud, Colombo, Massimo, Lazarus, Jeffrey V

    Published in World journal of gastroenterology : WJG (14-08-2020)
    “…The hepatitis C virus (HCV) is estimated to affect 71 million people worldwide. In 2016, the World Health Organization adopted the first global health sector…”
    Get full text
    Journal Article